Cidara Therapeutics, Inc.

CDTXNASDAQHealthcare

$221.38

+$0.00(+0.00%)

Market Cap$5.6B

P/E Ratio—

52W High$221.42

52W Low$15.22

Avg Volume1.4M

Open$221.38

Beta1.53

Cash on Hand Financials Revenue

Cidara Therapeutics, Inc. (CDTX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CDTX · cash on hand · updated Dec 31, 2024

Core cash position

as of Dec 31, 2024

Cash & Short-Term Investments (CCE + ST Investments)

$189.8M▲ +430.6% vs prior year

FY · as of Dec 31, 2024 · Reported in USD

Cash & Cash Equiv. (CCE)

$189.8M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+430.6%

vs prior fiscal year

Latest Quarter

$293.7M

Q3 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2024

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$189.8MCash on Hand

Total Debt$3.6MTotal Debt

Net Cash / Net Debt+$186.2MNet Cash Position

Cash vs Debt Ratio

Cash 98%Cidara Therapeutics, Inc. cash as % of market cap: 3.38%% · MCap $6BDebt 2%

Cidara Therapeutics, Inc. has a net cash position of $186.2M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$189.8M − $3.6M = +$186.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

CDTX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

CDTX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2024LatestFY$189.8M+430.6%

Dec 31, 2023FY$35.8M+9.3%

Dec 31, 2022FY$32.7M-47.4%

Dec 31, 2021FY$62.3M+73.4%

Dec 31, 2020FY$35.9M-28.6%

CDTX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

CDTX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Cidara Therapeutics, Inc.YOU

CDTX

$189.8M$6B3.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Cidara Therapeutics, Inc. (CDTX) cash on hand as of December 31, 2024 is $189.8M, comprising $189.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Cidara Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Cidara Therapeutics, Inc. cash reserves or cash position.

Cidara Therapeutics, Inc. annual cash on hand history shows increased +430.6% in 2024: increased +430.6% in 2024. Cidara Therapeutics, Inc. cash reserves in 2024 reflect the company's capital allocation strategy.

Cidara Therapeutics, Inc. carries total debt of $3.6M against cash of $189.8M, resulting in a net cash position of +$186.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

CDTX cash on hand · 5 questions

As of December 31, 2024, Cidara Therapeutics, Inc. (CDTX) has $189,825,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $189,825,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (September 30, 2025): $293,651,000. Data sourced from the annual 10-K filing via FMP.

CDTX cash on handCDTX cash reservesCDTX cash 2024how much cash does CDTX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Cidara Therapeutics, Inc. · Cidara Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2024